Video is loading...
Targeted Lymphoma Drug Works After Others Fail
MD Anderson’s Dr. Michelle Fanale, Hodgkin lymphoma survivor Alexandra Medina and research nurse Rinata Simien talk about newly approved drug brentuximab vedotin.
Title: Targeted Lymphoma Drug Works After Others Fail
Summary: MD Anderson’s Dr. Michelle Fanale, Hodgkin lymphoma survivor Alexandra Medina and research nurse Rinata Simien talk about newly approved drug brentuximab vedotin.
Keywords: brentuximab vedotin, lymphoma, hodgkin, Michelle Fanale, new, research, fda
Transcript: